Literature DB >> 28271171

Histological and Ultrastructural Characterization of Alkaptonuric Tissues.

Lia Millucci1, Giulia Bernardini1, Adriano Spreafico2, Maurizio Orlandini1, Daniela Braconi1, Marcella Laschi1, Michela Geminiani1, Pietro Lupetti3, Giovanna Giorgetti4, Cecilia Viti4, Bruno Frediani5, Barbara Marzocchi1,6, Annalisa Santucci7.   

Abstract

Alkaptonuria (AKU) is a hereditary disorder that results from altered structure and function of homogentisate 1,2 dioxygenase (HGD). This enzyme, predominantly produced by liver and kidney, is responsible for the breakdown of homogentisic acid (HGA), an intermediate in the tyrosine degradation pathway. A deficient HGD activity causes HGA levels to rise systemically. The disease is clinically characterized by homogentisic aciduria, bluish-black discoloration of connective tissues (ochronosis) and joint arthropathy. Additional manifestations are cardiovascular abnormalities, renal, urethral and prostate calculi and scleral and ear involvement. While the radiological aspect of ochronotic spondyloarthropathy is known, there are only few data regarding an exhaustive ultrastructural and histologic study of different tissues in AKU. Moreover, an in-depth analysis of tissues from patients of different ages, having varied symptoms, is currently lacking. A complete microscopic and ultrastructural analysis of different AKU tissues, coming from six differently aged patients, is here presented thus significantly contributing to a more comprehensive knowledge of this ultra-rare pathology.

Entities:  

Keywords:  Alkaptonuria; Amyloidosis; Histology; Tissues

Mesh:

Year:  2017        PMID: 28271171     DOI: 10.1007/s00223-017-0260-9

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  6 in total

Review 1.  Chondrocyte death involvement in osteoarthritis.

Authors:  S Salucci; E Falcieri; M Battistelli
Journal:  Cell Tissue Res       Date:  2022-05-26       Impact factor: 4.051

2.  Ochronotic arthropathy-a rare clinical case.

Authors:  André Couto; André Sá Rodrigues; Paulo Oliveira; Manuel Seara
Journal:  Oxf Med Case Reports       Date:  2018-08-28

3.  Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria.

Authors:  A M Milan; A T Hughes; A S Davison; M Khedr; J Rovensky; E E Psarelli; T F Cox; N P Rhodes; J A Gallagher; L R Ranganath
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

Review 4.  Alkaptonuria: Current Perspectives.

Authors:  Andrea Zatkova; Lakshminarayan Ranganath; Ludevit Kadasi
Journal:  Appl Clin Genet       Date:  2020-01-23

Review 5.  Melanins as Sustainable Resources for Advanced Biotechnological Applications.

Authors:  Hanaa A Galeb; Emma L Wilkinson; Alison F Stowell; Hungyen Lin; Samuel T Murphy; Pierre L Martin-Hirsch; Richard L Mort; Adam M Taylor; John G Hardy
Journal:  Glob Chall       Date:  2020-11-25

6.  Towards a Precision Medicine Approach Based on Machine Learning for Tailoring Medical Treatment in Alkaptonuria.

Authors:  Ottavia Spiga; Vittoria Cicaloni; Anna Visibelli; Alessandro Davoli; Maria Ausilia Paparo; Maurizio Orlandini; Barbara Vecchi; Annalisa Santucci
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.